HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mitchum To Get First Ad Campaign In More Than Decade

This article was originally published in The Rose Sheet

Executive Summary

Revlon will resume advertising for its Mitchum deodorant and antiperspirant brand after a more than 10-year hiatus in an effort to augment brand sales and market share, the firm said

You may also be interested in...



Revlon Launches “Provocative” Mitchum Campaign To Revitalize Brand

Revlon is launching the first significant promotional effort behind its Mitchum antiperspirant/deodorant brand in nearly two decades with a new "Mitchum Man" ad campaign that seeks to connect with men in their 30s and 40s through a "straightforward" and "provocative" approach, according to the company

Revlon Launches “Provocative” Mitchum Campaign To Revitalize Brand

Revlon is launching the first significant promotional effort behind its Mitchum antiperspirant/deodorant brand in nearly two decades with a new "Mitchum Man" ad campaign that seeks to connect with men in their 30s and 40s through a "straightforward" and "provocative" approach, according to the company

Revlon 2002 Marketing Initiatives Aim For Consumption Growth In Color

Revlon will install a redesigned color cosmetics wall display for its namesake brand in approximately 5,000 U.S. mass market doors by the end of 2002, the firm said during its fourth quarter sales and earnings call with investors Feb. 25

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel